Visit COVID-19 resources

[Skip to Content]

Effect of cooling proparacaine 0.5% eye drops on patient’s comfort during instillation – (Eye Journal AOP)

Apr 24
2015

Effect of cooling proparacaine 0.5% eye drops on patient’s comfort during instillation Eye advance online publication, April 24 2015. doi:10.1038/eye.2015.59 Authors: J Hu Youwei & B Chang

  • 24 April 2015

Vision standards for driving: what ophthalmologists need to know – (Eye Journal AOP)

Apr 17
2015

Vision standards for driving: what ophthalmologists need to know Eye advance online publication, April 17 2015. doi:10.1038/eye.2015.38 Author: G B Rees

  • 17 April 2015

Defining response to anti-VEGF therapies in neovascular AMD – (Eye Journal AOP)

Apr 17
2015

Defining response to anti-VEGF therapies in neovascular AMD Eye advance online publication, April 17 2015. doi:10.1038/eye.2015.48 Authors: W M Amoaku, U Chakravarthy, R Gale, M Gavin, F Ghanchi, J Gibson, S Harding, R L Johnston, S Kelly, A Lotery, S Mahmood, G Menon, S Sivaprasad, J Talks, A Tufail & Y Yang

  • 17 April 2015

Long term patient-reported benefit from ptosis surgery – (Eye Journal AOP)

Apr 17
2015

Long term patient-reported benefit from ptosis surgery Eye advance online publication, April 17 2015. doi:10.1038/eye.2015.54 Authors: N Maycock, C MacGregor, D A Saunders & B Parkin

  • 17 April 2015

Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications – (Eye Journal AOP)

Apr 10
2015

Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications Eye advance online publication, April 10 2015. doi:10.1038/eye.2015.40 Authors: M Saini, R Dhiman, T Dada, R Tandon & M Vanathi

  • 10 April 2015